Tower Research Capital (TRC)’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Buy |
13,436
+6,217
| +86% | +$6.96K | ﹤0.01% | 3822 |
|
|
2025
Q1 | $8.3K | Buy |
7,219
+3,780
| +110% | +$4.35K | ﹤0.01% | 3905 |
|
|
2024
Q4 | $21K | Buy |
3,439
+2,510
| +270% | +$15.3K | ﹤0.01% | 3148 |
|
|
2024
Q3 | $15.4K | Sell |
929
-2,699
| -74% | -$44.6K | ﹤0.01% | 3413 |
|
|
2024
Q2 | $24.9K | Buy |
3,628
+3,370
| +1,306% | +$23.2K | ﹤0.01% | 3623 |
|
|
2024
Q1 | $2.49K | Sell |
258
-1,284
| -83% | -$12.4K | ﹤0.01% | 5025 |
|
|
2023
Q4 | $12.8K | Sell |
1,542
-1,356
| -47% | -$11.3K | ﹤0.01% | 4013 |
|
|
2023
Q3 | $24.2K | Buy |
2,898
+382
| +15% | +$3.19K | ﹤0.01% | 3203 |
|
|
2023
Q2 | $23.2K | Sell |
2,516
-3,606
| -59% | -$33.3K | ﹤0.01% | 3227 |
|
|
2023
Q1 | $84K | Buy |
6,122
+5,524
| +924% | +$75.8K | ﹤0.01% | 2021 |
|
|
2022
Q4 | $10K | Sell |
598
-1,421
| -70% | -$23.8K | ﹤0.01% | 4013 |
|
|
2022
Q3 | $46K | Sell |
2,019
-2,833
| -58% | -$64.5K | ﹤0.01% | 3231 |
|
|
2022
Q2 | $87K | Sell |
4,852
-5,971
| -55% | -$107K | ﹤0.01% | 2401 |
|
|
2022
Q1 | $289K | Buy |
10,823
+8,736
| +419% | +$233K | ﹤0.01% | 1487 |
|
|
2021
Q4 | $61K | Buy |
2,087
+1,301
| +166% | +$38K | ﹤0.01% | 2612 |
|
|
2021
Q3 | $52K | Sell |
786
-66
| -8% | -$4.37K | ﹤0.01% | 2934 |
|
|
2021
Q2 | $71K | Sell |
852
-751
| -47% | -$62.6K | ﹤0.01% | 2722 |
|
|
2021
Q1 | $123K | Buy |
1,603
+652
| +69% | +$50K | ﹤0.01% | 2427 |
|
|
2020
Q4 | $84K | Sell |
951
-303
| -24% | -$26.8K | ﹤0.01% | 2521 |
|
|
2020
Q3 | $92K | Sell |
1,254
-1,700
| -58% | -$125K | ﹤0.01% | 3205 |
|
|
2020
Q2 | $216K | Buy |
2,954
+2,752
| +1,362% | +$201K | 0.01% | 1720 |
|
|
2020
Q1 | $11K | Buy |
+202
| New | +$11K | ﹤0.01% | 1971 |
|